Schaumburg, IL, June 20, 2023 (GLOBE NEWSWIRE) -- The American Society for Dermatologic Surgery (ASDS) is pleased to announce the registration launch of the 2023 ASDS Annual Meeting, which will take ...
The Society's awards recognize the dermatologic surgeons who have gone above and beyond for the organization and participated in activities that advance the specialty. The 2024 awards were presented ...
Each year, attendees say they look forward to seeing friends, meeting new colleagues and building rapport with industry representatives. · GlobeNewswire Inc. Schaumburg, IL, July 14, 2025 (GLOBE ...
ASDS member physicians voted for new leaders to step into the offices of Vice President and Treasurer, as well as three Board of Directors members and an ASDS Nominating Committee member. Their terms ...
ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it presented new data from its Injectable Aesthetics portfolio and pipeline at ...
ROLLING MEADOWS, Ill., Oct. 28, 2019 /PRNewswire-PRWeb/ -- The American Society for Dermatologic Surgery (ASDS) recently awarded Tina S. Alster, MD, Sabrina G. Fabi, MD, and Matthew Lin, MD, with the ...
Autism spectrum disorders (ASDs) are a class of neurodevelopmental disorders defined by qualitative impairments in social functioning and communication, often accompanied by repetitive and stereotyped ...
ZUG, Switzerland--(BUSINESS WIRE)--Galderma today announced new phase III data from the READY-4 clinical trial, demonstrating the long-term safety of RelabotulinumtoxinA (Relfydess ™) for frown lines ...
The American Society for Dermatologic Surgery (ASDS) multispecialty Soft-tissue Fillers Guideline Task Force has released its evidence-based recommendations for physicians performing injectable filler ...
Webinar Date/Time: Thursday, April 20th, 2023 4:00pm GMT | 11:00 am EDT | 5:00 pm CEST Follow the complete journey of amorphous solid dispersions (ASDs), starting from the early formulation stage to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results